The Independent Uganda: You get the Truth we Pay the Price
JERUSALEM | Xinhua | A group of Israeli, Chinese and German researchers found early clues that help explain why some cancer patients respond to immunotherapy while others do not, the Israel Institute of Technology said in a statement Wednesday.
In their study, published in the journal Cancer Cell, the researchers found that what happens inside a tumor shortly after treatment begins helps determine whether the treatment will work.
They studied tumor and immune system changes during early treatment and found that some tumors developed features that enabled immune cells to attack cancer more effectively, while others did not.
The findings suggested that doctors may eventually be able to look at these early changes to better predict whether a patient is responding to treatment.
The researchers said the findings could help improve cancer care by allowing doctors to identify ineffective treatments earlier and consider other options sooner. ■
